Sponsors (2)
The bill seeks to reduce PBM conflicts of interest and lower patient drug costs by imposing fiduciary duties and stronger remedies, but it risks higher compliance costs, reduced vendor flexibility, and market exit by smaller PBMs that could raise premiums or limit plan choices.
Middle-class families, plan participants, and taxpayers gain stronger fiduciary protections because PBMs and similar entities would be legally required to act in plans' best interests when managing drug networks and rebates.
Middle-class families and plan participants could face lower out-of-pocket drug costs if fiduciary duties reduce self-dealing and lead to pass-through of rebates or discounts to plans or beneficiaries.
Plan sponsors and participants gain stronger legal remedies because contracts trying to indemnify fiduciary PBMs or shield them from liability would be void and indemnification would be prohibited.
Employers and enrollees (including middle-class families and taxpayers) may face higher premiums or fees if PBMs and insurers pass increased compliance and litigation costs onto plans.
Smaller PBMs or plan sponsors could exit the market or raise prices to cover increased legal risk, reducing competition and potentially limiting plan choices for small-business owners, employers, and employees.
Plan sponsors and administrators may lose administrative flexibility if covered service providers cannot serve as the 'responsible plan fiduciary' for disclosures, complicating plan operations and vendor arrangements.
Based on analysis of 2 sections of legislative text.
Treats PBMs and similar entities as ERISA fiduciaries for group health plans, expands disclosure and fiduciary duties, voids contract clauses shielding them from liability, phased in after 12 months.
Introduced December 18, 2025 by Jake Auchincloss · Last progress December 18, 2025
Treats pharmacy benefit managers (PBMs) and similar drug-network or claims-processing entities as ERISA fiduciaries for group health plans. It expands ERISA disclosure and fiduciary-responsibility rules to cover those entities, forbids contract clauses that indemnify or shield them from fiduciary liability, makes related technical changes, and phases the new rules in for plan years that begin at least 12 months after the law is enacted.